Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


04.02.2019

2 Acta Ophthalmol
2 Am J Ophthalmol
1 Atherosclerosis
1 BMC Ophthalmol
9 Diabet Med
4 Diabetes
10 Diabetes Care
1 Diabetes Educ
4 Diabetes Obes Metab
4 Diabetologia
1 J Clin Endocrinol Metab
1 J Diabetes Complications
1 J Pediatr
2 JAMA
1 Lancet Diabetes Endocrinol
1 N Engl J Med
1 Obstet Gynecol
2 Pediatr Diabetes
7 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Ophthalmol

  1. TAYYARI F, Khuu LA, Sivak JM, Flanagan JG, et al
    Retinal blood oxygen saturation and aqueous humour biomarkers in early diabetic retinopathy.
    Acta Ophthalmol. 2019 Jan 28. doi: 10.1111/aos.14016.
    PubMed     Text format     Abstract available

  2. KAIZU Y, Nakao S, Arima M, Wada I, et al
    Capillary dropout is dominant in deep capillary plexus in early diabetic retinopathy in optical coherence tomography angiography.
    Acta Ophthalmol. 2019 Jan 28. doi: 10.1111/aos.14041.
    PubMed     Text format    


    Am J Ophthalmol

  3. PAVKOV ME, Harding JL, Chou CF, Saaddine JB, et al
    Prevalence of Diabetic Retinopathy and Associated Mortality Among Diabetic Adults With and Without Chronic Kidney Disease.
    Am J Ophthalmol. 2019;198:200-208.
    PubMed     Text format     Abstract available

  4. ROSEN RB, Andrade Romo JS, Krawitz BD, Mo S, et al
    Earliest Evidence of Preclinical Diabetic Retinopathy Revealed using OCT Angiography (OCTA) Perfused Capillary Density.
    Am J Ophthalmol. 2019 Jan 25. pii: S0002-9394(19)30025.
    PubMed     Text format     Abstract available


    Atherosclerosis

  5. SAEED A, Sun W, Agarwala A, Virani SS, et al
    Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study.
    Atherosclerosis. 2018;282:52-56.
    PubMed     Text format     Abstract available


    BMC Ophthalmol

  6. MCLAUGHLIN PJ, Sassani JW, Titunick MB, Zagon IS, et al
    Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes.
    BMC Ophthalmol. 2019;19:35.
    PubMed     Text format     Abstract available


    Diabet Med

  7. HILDEN K, Hanson U, Persson M, Magnuson A, et al
    Gestational diabetes and adiposity are independent risk factors for perinatal outcomes: a population based cohort study in Sweden.
    Diabet Med. 2019;36:151-157.
    PubMed     Text format     Abstract available

  8. HAUFFE F, Schaefer-Graf UM, Fauzan R, Schohe AL, et al
    Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection.
    Diabet Med. 2019;36:158-166.
    PubMed     Text format     Abstract available

  9. CHOUDHURY M, Taylor P, Morgan PH, Duckers J, et al
    Association between HbA1c and the development of cystic fibrosis-related diabetes.
    Diabet Med. 2019 Jan 30. doi: 10.1111/dme.13912.
    PubMed     Text format     Abstract available

  10. LIVINGSTONE R, Boyle JG, Petrie JR
    How tightly controlled do fluctuations in blood glucose levels need to be to reduce the risk of developing complications in people with Type 1 diabetes?
    Diabet Med. 2019 Jan 30. doi: 10.1111/dme.13911.
    PubMed     Text format     Abstract available

  11. LUTSKI M, Zucker I, Zadik Z, Libruder C, et al
    Prevalence of diabetes among children treated with growth hormone in Israel.
    Diabet Med. 2019 Jan 28. doi: 10.1111/dme.13910.
    PubMed     Text format     Abstract available

  12. GROSSOEHME DH, Smith E, Standiford D, Morwessel N, et al
    Understanding adolescent and parent acceptability and feasibility experience in a large Type 1 diabetes mellitus behavioural trial.
    Diabet Med. 2019 Jan 30. doi: 10.1111/dme.13913.
    PubMed     Text format     Abstract available

  13. CUNDY T, Holt RIG
    Assessing the outcomes of pregnancies of women with diabetes.
    Diabet Med. 2019;36:139-141.
    PubMed     Text format    

  14. STOYANOVA D, Stratmann B, Schwandt A, Heise N, et al
    Heart failure among people with Type 2 diabetes mellitus: real-world data of 289 954 people from a diabetes database.
    Diabet Med. 2019 Jan 30. doi: 10.1111/dme.13915.
    PubMed     Text format     Abstract available

  15. SOON WHK, Guelfi KJ, Davis EA, Smith GJ, et al
    Effect of combining pre-exercise carbohydrate intake and repeated short sprints on the blood glucose response to moderate-intensity exercise in young individuals with Type 1 diabetes.
    Diabet Med. 2019 Jan 30. doi: 10.1111/dme.13914.
    PubMed     Text format     Abstract available


    Diabetes

  16. MOON KC, Suh HS, Kim KB, Han SK, et al
    Potential of Allogeneic Adipose-Derived Stem Cell - Hydrogel Complex for Treating Diabetic Foot Ulcers.
    Diabetes. 2019 Jan 24. pii: db18-0699. doi: 10.2337/db18-0699.
    PubMed     Text format     Abstract available

  17. VOUILLARMET J, Josset-Lamaugarny A, Michon P, Saumet JL, et al
    Neurovascular Response to Pressure in Patients with Diabetic Foot Ulcer.
    Diabetes. 2019 Jan 24. pii: db18-0694. doi: 10.2337/db18-0694.
    PubMed     Text format     Abstract available

  18. SHEAN-YOUNG LEE P, Gao N, Dike M, Shkilnyy O, et al
    Opposing Effects of Neuropilin-1 and -2 on Sensory Nerve Regeneration in Wounded Corneas: Role of Sema3C in Ameliorating Diabetic Neurotrophic Keratopathy.
    Diabetes. 2019 Jan 24. pii: db18-1172. doi: 10.2337/db18-1172.
    PubMed     Text format     Abstract available

  19. ZHU H, Chen B, Cheng Y, Zhou Y, et al
    Insulin Therapy of Gestational Diabetes Does Not Fully Protect Offspring from Diet-Induced Metabolic Disorders.
    Diabetes. 2019 Jan 29. pii: db18-1151. doi: 10.2337/db18-1151.
    PubMed     Text format     Abstract available


    Diabetes Care

  20. FAYFMAN M, Galindo RJ, Rubin DJ, Mize DL, et al
    A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes.
    Diabetes Care. 2019 Jan 24. pii: dc18-1760. doi: 10.2337/dc18-1760.
    PubMed     Text format     Abstract available

  21. OVERBEEK JA, van Herk-Sukel MPP, Vissers PAJ, van der Heijden AAWA, et al
    Type 2 Diabetes, but Not Insulin (Analog) Treatment, Is Associated With More Advanced Stages of Breast Cancer: A National Linkage of Cancer and Pharmacy Registries.
    Diabetes Care. 2019 Jan 24. pii: dc18-2146. doi: 10.2337/dc18-2146.
    PubMed     Text format     Abstract available

  22. BENOIT SR, Swenor B, Geiss LS, Gregg EW, et al
    Eye Care Utilization Among Insured People With Diabetes, U.S. 2010-2014.
    Diabetes Care. 2019 Jan 24. pii: dc18-0828. doi: 10.2337/dc18-0828.
    PubMed     Text format     Abstract available

  23. MONTVIDA O, Cai X, Paul SK
    Cardiovascular Risk Factor Burden in U.S. People With Incident Type 2 Diabetes Receiving Antidiabetic and Cardioprotective Therapies.
    Diabetes Care. 2019 Jan 24. pii: dc18-1865. doi: 10.2337/dc18-1865.
    PubMed     Text format     Abstract available

  24. TAPIA G, Marild K, Dahl SR, Lund-Blix NA, et al
    Maternal and Newborn Vitamin D-Binding Protein, Vitamin D Levels, Vitamin D Receptor Genotype, and Childhood Type 1 Diabetes.
    Diabetes Care. 2019 Jan 28. pii: dc18-2176. doi: 10.2337/dc18-2176.
    PubMed     Text format     Abstract available

  25. LI G, Prior JC, Leslie WD, Thabane L, et al
    Frailty and Risk of Fractures in Patients With Type 2 Diabetes.
    Diabetes Care. 2019 Jan 28. pii: dc18-1965. doi: 10.2337/dc18-1965.
    PubMed     Text format     Abstract available

  26. DU T, Fernandez C, Barshop R, Guo Y, et al
    Sex Differences in Cardiovascular Risk Profile From Childhood to Midlife Between Individuals Who Did and Did Not Develop Diabetes at Follow-up: The Bogalusa Heart Study.
    Diabetes Care. 2019 Jan 28. pii: dc18-2029. doi: 10.2337/dc18-2029.
    PubMed     Text format     Abstract available

  27. FINNE P, Groop PH, Arffman M, Kervinen M, et al
    Cumulative Risk of End-Stage Renal Disease Among Patients With Type 2 Diabetes: A Nationwide Inception Cohort Study.
    Diabetes Care. 2019 Jan 28. pii: dc18-1485. doi: 10.2337/dc18-1485.
    PubMed     Text format     Abstract available

  28. LAITEERAPONG N, Ham SA, Huang ES, Karter AJ, et al
    Response to Comment on Laiteerapong et al. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care 2019;42:XXXX-XXXX.
    Diabetes Care. 2019 Jan 24. pii: dci18-0036. doi: 10.2337/dci18-0036.
    PubMed     Text format    

  29. HULMAN A, Bjerg L, Carstensen B
    Comment on Laiteerapong et al. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care 2019;42:XXXX-XXXX.
    Diabetes Care. 2019 Jan 24. pii: dc18-1779. doi: 10.2337/dc18-1779.
    PubMed     Text format    


    Diabetes Educ

  30. DATYE K, Bonnet K, Schlundt D, Jaser S, et al
    Experiences of Adolescents and Emerging Adults Living With Type 1 Diabetes.
    Diabetes Educ. 2019 Jan 25:145721718825342. doi: 10.1177/0145721718825342.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  31. MCGUIRE DK, Marx N, Johansen OE, Inzucchi SE, et al
    FDA Guidance on Antihyperglycemic Therapies for Type 2 Diabetes: One Decade Later.
    Diabetes Obes Metab. 2019 Jan 28. doi: 10.1111/dom.13645.
    PubMed     Text format     Abstract available

  32. YU L, Li X, Zhang Z, Du P, et al
    Dimorphic autoantigenic and protective effects of Reg2 peptide in the treatment of diabetic beta-cell loss.
    Diabetes Obes Metab. 2019 Jan 28. doi: 10.1111/dom.13644.
    PubMed     Text format     Abstract available

  33. LEITE NC, Viegas BB, Villela-Nogueira CA, Carlos FO, et al
    Efficacy of Diacerein in Reducing Liver Steatosis and Fibrosis in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: a Randomized, Placebo-Controlled Trial.
    Diabetes Obes Metab. 2019 Jan 28. doi: 10.1111/dom.13643.
    PubMed     Text format     Abstract available

  34. TOYAMA T, Neuen BL, Jun M, Ohkuma T, et al
    Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and meta-analysis.
    Diabetes Obes Metab. 2019 Jan 29. doi: 10.1111/dom.13648.
    PubMed     Text format     Abstract available


    Diabetologia

  35. VERMA S, McMurray JJV
    SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review.
    Diabetologia. 2018;61:2108-2117.
    PubMed     Text format     Abstract available

  36. THOMAS MC, Cherney DZI
    The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure.
    Diabetologia. 2018;61:2098-2107.
    PubMed     Text format     Abstract available

  37. RIEG T, Vallon V
    Development of SGLT1 and SGLT2 inhibitors.
    Diabetologia. 2018;61:2079-2086.
    PubMed     Text format     Abstract available

  38. GHEZZI C, Loo DDF, Wright EM
    Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2.
    Diabetologia. 2018;61:2087-2097.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  39. SIMON MC, Moller-Horigome A, Strassburger K, Nowotny B, et al
    Correlates of Insulin-Stimulated glucose Disposal in Recent Onset Type 1 and Type 2 Diabetes.
    J Clin Endocrinol Metab. 2019 Jan 28. pii: 5303356. doi: 10.1210/jc.2018-02057.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  40. CHEUNG NW, Wong KYC, Kovoor P, McLean M, et al
    Stress hyperglycemia: A prospective study examining the relationship between glucose, cortisol and diabetes in myocardial infarction.
    J Diabetes Complications. 2019 Jan 4. pii: S1056-8727(18)31063.
    PubMed     Text format     Abstract available


    J Pediatr

  41. HANSEN DW
    50 Years Ago in The Journal of Pediatrics: Hyperosmolality Complicating Diabetes Mellitus in Childhood.
    J Pediatr. 2019;205:223.
    PubMed     Text format    


    JAMA

  42. LUO J, Khan NF, Manetti T, Rose J, et al
    Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries With Type 2 Diabetes.
    JAMA. 2019;321:374-384.
    PubMed     Text format     Abstract available

  43. LIPSKA KJ
    Insulin Analogues for Type 2 Diabetes.
    JAMA. 2019;321:350-351.
    PubMed     Text format    


    Lancet Diabetes Endocrinol

  44. HALBERG IB, Lyby K, Wassermann K, Heise T, et al
    Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial.
    Lancet Diabetes Endocrinol. 2019 Jan 21. pii: S2213-8587(18)30372.
    PubMed     Text format     Abstract available


    N Engl J Med

  45. KARANDINOS G, Bourgois P
    The Structural Violence of Hyperincarceration - A 44-Year-Old Man with Back Pain.
    N Engl J Med. 2019;380:205-209.
    PubMed     Text format    


    Obstet Gynecol

  46. BERGHELLA V, Caissutti C, Saccone G, Khalifeh A, et al
    One-Step Approach to Identifying Gestational Diabetes Mellitus: Association With Perinatal Outcomes.
    Obstet Gynecol. 2019;133:383.
    PubMed     Text format    


    Pediatr Diabetes

  47. BELTRAND J, Baptiste A, Busiah K, Bouazza N, et al
    Glibenclamide oral suspension: Suitable and effective in Patients with Neonatal Diabetes.
    Pediatr Diabetes. 2019 Jan 26. doi: 10.1111/pedi.12823.
    PubMed     Text format     Abstract available

  48. STEKELENBURG C, Gerster K, Blouin JL, Lang-Muritano M, et al
    Exome sequencing identifies a de novo FOXA2 variant in a patient with syndromic diabetes.
    Pediatr Diabetes. 2019 Jan 26. doi: 10.1111/pedi.12814.
    PubMed     Text format     Abstract available


    PLoS One

  49. NAYAK VKR, Raghurama Nayak K, Vidyasagar S, Kamath A, et al
    Body composition analysis, anthropometric indices and lipid profile markers as predictors for prediabetes.
    PLoS One. 2018;13:e0200775.
    PubMed     Text format     Abstract available

  50. YEOW TP, Aun ES, Hor CP, Lim SL, et al
    Challenges in the classification and management of Asian youth-onset diabetes mellitus- lessons learned from a single centre study.
    PLoS One. 2019;14:e0211210.
    PubMed     Text format     Abstract available

  51. GRIEVINK H, Kuzmina N, Chevion M, Drenger B, et al
    Sevoflurane postconditioning is not mediated by ferritin accumulation and cannot be rescued by simvastatin in isolated streptozotocin-induced diabetic rat hearts.
    PLoS One. 2019;14:e0211238.
    PubMed     Text format     Abstract available

  52. GONDALIYA P, Dasare A, Srivastava A, Kalia K, et al
    Correction: miR29b regulates aberrant methylation in In-Vitro diabetic nephropathy model of renal proximal tubular cells.
    PLoS One. 2019;14:e0211591.
    PubMed     Text format     Abstract available

  53. MONTANIER N, Bernard L, Lambert C, Pereira B, et al
    Prospective evaluation of a dynamic insulin infusion algorithm for non critically-ill diabetic patients: A before-after study.
    PLoS One. 2019;14:e0211425.
    PubMed     Text format     Abstract available

  54. MUTYAMBIZI C, Booysen F, Stokes A, Pavlova M, et al
    Lifestyle and socio-economic inequalities in diabetes prevalence in South Africa: A decomposition analysis.
    PLoS One. 2019;14:e0211208.
    PubMed     Text format     Abstract available

  55. MORALES-CANO D, Callejo M, Barreira B, Mondejar-Parreno G, et al
    Elevated pulmonary arterial pressure in Zucker diabetic fatty rats.
    PLoS One. 2019;14:e0211281.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: